PharmaShots | Incisive News in 3 Shots

Subscribe Now

REMDACTA Study

Roche Initiates P-III REMDACTA Study Evaluating Actemra (tocilizumab) + Remdesivir for Hospitalized Patients with Severe COVID-19 Pneumonia

Roche Initiates P-III REMDACTA Study Evaluating Actemra (tocilizumab) + Remdesivir for Hospitalized Patients with Severe COVID-19...

May 28, 2020

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us